EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model

计划入组 8 人 · 首次发布于 2009 年 8 月 13 日

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

首次发布于 2015 年 9 月 2 日

Pilot Window of Opportunity Trial (POET)

计划入组 10 人 · 首次发布于 2023 年 11 月 13 日

EP4 prostanoid receptor antagonists (East China Normal University)

EP4 agonist(Sosei Heptares)

EP4 agonists (inflammatory disease)

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

Kainova Therapeutics Reports Positive Phase I Results for Oral EP4 Receptor Antagonist DT-9081 in Advanced Solid Tumors

Domain Therapeutics to Showcase Novel GPCR-Targeting Oncology Programs at AACR 2025

ONO-4578 EP4 Antagonist Combination Shows Significant PFS Improvement in Advanced Gastric Cancer